The Healthcare Technology Report with RJ Lumba

Musculoskeletal Recovery At Scale: Breg’s David Mowry

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Dave Mowry, Executive Chairman and CEO of Breg, a musculoskeletal health medical device company providing orthopedic bracing, cold therapy solutions, and software-enabled services that support durable medical equipment management. Breg works with a large orthopedic footprint, partnering with thousands of clinics and providers and distributing products globally through a network spanning nearly 60 countries.
Dave stepped in as interim CEO in May 2024 and was appointed CEO in September 2024, while continuing as Chairman. He brings more than 30 years of medical device leadership experience, including CEO roles at Cutera and at Vyaire Medical, and he previously led Tornier as president and CEO prior to its acquisition.
Dave supports Firefighters for Healing. To learn more about this organization click here.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

A Remedy for Age-Related Muscle Loss: Immunis’ Hans Keirstead

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Hans Keirstead, Chairman of the Board at Immunis, a clinical-stage biotechnology company developing stem cell-derived biologics to address age-related diseases and immune dysfunction. Immunis’ investigational therapy, IMM01-STEM, is a stem cell-derived secretome designed to modulate immune health and improve muscle mass and function, with initial clinical work focused on sarcopenia-related conditions. 
Hans is a stem cell researcher and biotech entrepreneur with prior experience developing therapies across neurology, immune disorders, and oncology. He previously served as a full professor of anatomy and neurobiology at UC Irvine and has held leadership and board roles across multiple biotechnology organizations.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Multi-Specialty Virtual Care: AmplifyMD’s Meena Mallipeddi

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Meena Mallipeddi, Co-Founder and CEO of AmplifyMD, a multi-specialty virtual care platform built to help hospitals and health systems expand timely specialty access across emergency, inpatient, and outpatient settings. AmplifyMD integrates into health system EMRs and pairs workflow automation and embedded AI tools with an on-demand network of remote specialists, offering coverage across 15 clinical service lines. The platform is used across all 50 states, supports nearly 400 programs, and helps hospitals reduce transfers and keep patients in-network when specialty capacity is constrained.
Meena co-founded AmplifyMD after years investing in healthcare and technology and has led the company’s expansion from its first hospital deployment into a national platform. Her background includes roles as an equity analyst and investor, and she is a frequent speaker on virtual care strategy and clinician workforce sustainability.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

AI For Medication Safety: MDI Health’s Brad Margolis

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Brad Margolis, CEO of MDI Health, a medication management platform used by payers and providers to identify patients at risk of adverse drug events and recommend evidence-based medication regimen changes. MDI Health analyzes claims and EMR data, incorporating factors like medical history, lab values, and kidney and liver function to generate patient-specific recommendations along with supporting clinical references. 
Brad joined MDI Health first as COO before becoming CEO. He brings nearly 25 years in healthcare, along with experience scaling health technology companies and advising healthcare organizations on growth and operations.
Brad supports Food on Foot. To learn more about this organization click here.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Generative Drug Design: Iktos’ Yann Gaston-Mathé

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Yann Gaston-Mathé, Co-Founder and CEO of Iktos, a company building AI and robotics tools for small-molecule drug discovery. Iktos offers Makya for generative molecular design and Spaya for retrosynthesis, alongside an AI-driven robotics platform that automates synthesis to accelerate the Design–Make–Test–Analyze cycle. The company also works in collaboration with pharma partners and is developing an in-house pipeline targeting oncology and autoimmune and inflammatory diseases.
Yann has spent more than two decades across pharma R&D, data analytics, and biotech entrepreneurship. He leads Iktos’ strategy and product development, drawing on experience spanning pharmaceutical research, consulting, and multiple company-building efforts.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Turning Clinical Data Into Evidence: Verantos’ Dan Riskin

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Dan Riskin, CEO and Founder of Verantos, a real-world evidence company focused on generating high-validity evidence for clinical, regulatory, and reimbursement use. Verantos de-identifies, enriches, and integrates data from electronic health records, medical claims, and product and disease registries, then applies artificial intelligence to generate research-grade evidence at scale for life sciences teams.
Dan founded Verantos after building healthcare technology companies at the intersection of medicine and software. He is also a clinical professor of surgery at Stanford and a congressional appointee to the U.S. Health IT Advisory Committee at HHS.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Turning Coverage Into Care: Aeroflow Health’s Casey Hite

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Casey Hite, CEO of Aeroflow Health, a personalized health partner that helps patients access medical equipment and supplies covered by insurance. Aeroflow Health guides patients through product selection, verifies coverage, submits required paperwork, and delivers curated supplies to the patient’s door. The company also partners with health plans and healthcare providers to support member satisfaction and patient care, combining technology with communication, education, and services designed to keep patients informed throughout the process.
Casey co-launched Aeroflow Healthcare in 2002 with his brother Don and has overseen the creation and growth of business lines including Aeroflow Mom & Baby, Motif Medical, Aeroflow Sleep, Aeroflow Urology, and Aeroflow Diabetes.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Bringing GI Therapies to Market: Phathom Pharmaceuticals’ Steve Basta

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Steve Basta, President and CEO of Phathom Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal (GI) diseases. The company has licensed exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB) and is building its commercial business around therapies for acid-related GI conditions.
Steve was appointed President and CEO and joined the Board of Directors in April 2025. He brings more than 25 years of leadership experience across biopharmaceutical, medical device, and digital health companies, including CEO roles at SaNOtize, Mahana Therapeutics, Menlo Therapeutics (now VYNE Therapeutics), AlterG, BioForm Medical, and Merz Aesthetics.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Building Enterprise Software Solutions: Jelvix’s Sasha Andrieiev

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Oleksandr (Sasha) Andrieiev, CEO and Co-Founder of Jelvix, a global software engineering company that provides development, integration, and IT consulting services for enterprises, scale-ups, and industry innovators. Jelvix provides custom software development, systems integration, SaaS engineering, and dedicated development teams serving clients across healthcare, financial services, real estate, insurance, and other sectors. With more than 15 years in operation, the company supports organizations throughout North America, Europe, and Asia with long-term technical partnerships.
Andrieiev has led Jelvix since its founding in 2011 and brings experience in entrepreneurship, software development leadership, and advisory work related to digital transformation and technology strategy. Earlier in his career, he built and managed technology-focused businesses in the private sector.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

Rewriting Biology at Scale: Constructive Bio’s Ola Wlodek

Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Ola Wlodek, CEO of Constructive Bio, a company developing technologies for large-scale genome writing and genetic code reprogramming. Spun out of Professor Jason Chin’s laboratory at the MRC Laboratory of Molecular Biology, Constructive Bio focuses on building programmable biomolecules and enabling cells to produce materials and therapeutics that conventional biology cannot.
Ola brings experience from across the Cambridge biotech ecosystem and previously served as Chief Operating Officer at Reflection Therapeutics. At Constructive Bio, she leads efforts to advance applications of synthetic genomics, from virus-resistant production strains to the biosynthesis of new classes of enzymes, pharmaceuticals, and biomaterials.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.